Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-024200
Filing Date
2018-04-06
Accepted
2018-04-06 16:11:17
Documents
1
Period of Report
2018-03-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1496
  Complete submission text file 0001209191-18-024200.txt   2846
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Issuer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2505 MERIDIAN PARKWAY, C/O CHIMERIX, INC SUITE 100 DURHAM NC 27713
Business Address
Greissing Ed (Reporting) CIK: 0001735359 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35867 | Film No.: 18743333